UB Paderborn / Katalog / Suche / in CDI

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

European journal of haematology, 2019-02, Vol.102 (2), p.111-122

2019

Link zum Volltext

Verfügbarkeit prüfen

Principles of care for acquired hemophilia

European journal of haematology, 2021-06, Vol.106 (6), p.762-773

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

British journal of haematology, 2023-01, Vol.200 (2), p.229-239

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management

Blood transfusion = Trasfusione del sangue, 2018-11, Vol.16 (6), p.535-544

2018

Link zum Volltext

Verfügbarkeit prüfen

Practical aspects of extended half-life products for the treatment of haemophilia

Therapeutic Advances in Hematology, 2018-09, Vol.9 (9), p.295-308

2018

Link zum Volltext

Verfügbarkeit prüfen

Practical considerations for nonfactor‐replacement therapies in the treatment of haemophilia with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.340-350

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice

European journal of haematology, 2012-05, Vol.88 (5), p.371-379

2012

Link zum Volltext

Verfügbarkeit prüfen

Hip and Knee Osteoarthritis in Patients with Chronic Myeloproliferative Neoplasms: A Cross-Sectional Study

Life (Basel, Switzerland), 2023-06, Vol.13 (6), p.1388

2023

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality of Life in Patients with Haemophilia and Its Association with Depressive Symptoms: A Study in Croatia and Slovenia

Psychiatria Danubina, 2021-01, Vol.33 (3), p.334-341

2021

Link zum Volltext

Verfügbarkeit prüfen

Switching treatments in haemophilia: is there a risk of inhibitor development?

European journal of haematology, 2015-04, Vol.94 (4), p.284-289

2015

Link zum Volltext

Verfügbarkeit prüfen

Tailoring care to haemophilia patients' needs: which specialty and when?

Blood transfusion = Trasfusione del sangue, 2015-10, Vol.13 (4), p.644-650

2015

Link zum Volltext

Verfügbarkeit prüfen

Hemophilia treatment in 2021: Choosing the”optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians

Blood reviews, 2022-03, Vol.52, p.100890-100890, Article 100890

2022

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in Croatia - Croatian Cooperative Group for Hematologic Diseases (CROHEM) study

Croatian medical journal, 2015-12, Vol.56 (6), p.550-557

2015

Link zum Volltext

Verfügbarkeit prüfen

Haemophilia B: Where are we now and what does the future hold?

Blood reviews, 2018-01, Vol.32 (1), p.52-60

2018

Link zum Volltext

Verfügbarkeit prüfen

Extensive Deep Venous Thrombosis in a Young Male Patient as the First Manifestation of a Rare Venous Anomaly - Inferior Vena Cava Duplication: Case Report

Acta clinica Croatica (Tisak), 2017-06, Vol.56 (2), p.338-343

2017

Link zum Volltext

Verfügbarkeit prüfen

Pain and pain management in haemophilia

Blood coagulation & fibrinolysis, 2016-12, Vol.27 (8), p.845-854

2016

Link zum Volltext

Verfügbarkeit prüfen

Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future

Blood transfusion = Trasfusione del sangue, 2014-07, Vol.12 (3), p.314-319

2014

Link zum Volltext

Verfügbarkeit prüfen

A case report of acute inferior myocardial infarction in a patient with severe hemophilia A after recombinant factor VIII infusion

Medicine (Baltimore), 2017-12, Vol.96 (52), p.e9075-e9075

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors

Blood advances, 2022-06, Vol.6 (11), p.3422-3432

2022

Link zum Volltext

Verfügbarkeit prüfen

Long‐term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-11, Vol.24 (6), p.e391-e394

2018

Link zum Volltext

Verfügbarkeit prüfen

Eltrombopag u liječenju aplastične anemije u Hrvatskoj – KROHEM-ova studija

Liječnički vjesnik, 2021-02, Vol.142 (11-12), p.372

2021

Link zum Volltext

Verfügbarkeit prüfen

Successful reversal of anticoagulant effect of superwarfarin poisoning with recombinant activated factor VII

Blood coagulation & fibrinolysis, 2005-06, Vol.16 (4), p.239-244

2005

Link zum Volltext

Verfügbarkeit prüfen

Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?

Thrombosis research, 2014-06, Vol.133 (6), p.967-971

2014

Link zum Volltext

Verfügbarkeit prüfen

Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors

Blood transfusion = Trasfusione del sangue, 2017-01, Vol.15 (1), p.77-84

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of and risk factors for urolithiasis in Croatian patients with hemophilia

International journal of hematology, 2021-05, Vol.113 (5), p.656-661

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

Principles of care for acquired hemophilia

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management

Practical aspects of extended half-life products for the treatment of haemophilia

Practical considerations for nonfactor‐replacement therapies in the treatment of haemophilia with inhibitors

Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice

Hip and Knee Osteoarthritis in Patients with Chronic Myeloproliferative Neoplasms: A Cross-Sectional Study

Health-Related Quality of Life in Patients with Haemophilia and Its Association with Depressive Symptoms: A Study in Croatia and Slovenia

Switching treatments in haemophilia: is there a risk of inhibitor development?

Tailoring care to haemophilia patients' needs: which specialty and when?

Hemophilia treatment in 2021: Choosing the”optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians

Venous thromboembolism in Croatia - Croatian Cooperative Group for Hematologic Diseases (CROHEM) study

Haemophilia B: Where are we now and what does the future hold?

Extensive Deep Venous Thrombosis in a Young Male Patient as the First Manifestation of a Rare Venous Anomaly - Inferior Vena Cava Duplication: Case Report

Pain and pain management in haemophilia

Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future

A case report of acute inferior myocardial infarction in a patient with severe hemophilia A after recombinant factor VIII infusion

Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors

Long‐term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial

Eltrombopag u liječenju aplastične anemije u Hrvatskoj – KROHEM-ova studija

Successful reversal of anticoagulant effect of superwarfarin poisoning with recombinant activated factor VII

Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?

Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors

Prevalence of and risk factors for urolithiasis in Croatian patients with hemophilia

Suchergebnisse filtern